Ovid: Phase 2 Study for Treatment of Cerebral Cavernous Malformations Is Expected to Initiate in H2
Ovid:治療腦部海綿狀血管畸形的2期臨床研究預計將於下半年開始。
Ovid: Phase 2 Study for Treatment of Cerebral Cavernous Malformations Is Expected to Initiate in H2
Ovid:治療腦部海綿狀血管畸形的2期臨床研究預計將於下半年開始。
譯文內容由第三人軟體翻譯。